Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER-based study.
Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER-based study.
复制标题
胃癌肝、肺、骨和脑转移的频率和临床病理特征:一项基于 SEER 的研究
DOI:
10.1002/cam4.1661
复制
发表时间:
2018-08
期刊:
影响因子:
4
通讯作者:
Xu RH
中科院分区:
文献类型:
--
作者:
Qiu MZ;Shi SM;Chen ZH;Yu HE;Sheng H;Jin Y;Wang DS;Wang FH;Li YH;Xie D;Zhou ZW;Yang DJ;Xu RH
The hematogenous metastatic pattern of gastric cancer (GC) was not fully explored. Here we analyzed the frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from GC patients. Data queried for this analysis included GC patients from the Surveillance, Epidemiology, and End Results Program database from 2010 to 2014. All of statistical analyses were performed using the Intercooled Stata 13.0 (Stata Corporation, College Station, TX). All statistical tests were two‐sided. Totally, there were 19 022 eligible patients for analysis. At the time of diagnosis, there were 7792 patients at stage IV, including 3218 (41.30%) patients with liver metastasis, 1126 (14.45%) with lung metastasis, 966 (12.40%) with bone metastasis and 151 (1.94%) with brain metastasis. GC patients with lung or liver metastasis have a higher risk of bone and brain metastasis than those without lung nor liver metastasis. Intestinal subtype had significantly higher rate of liver and lung metastasis, while diffuse type was more likely to have bone metastasis. Proximal stomach had significantly higher risk to develop metastasis than distal stomach. African‐Americans had the highest risk of liver metastasis and Caucasian had the highest prone to develop lung and brain metastasis. The median survival for patients with liver, lung, bone, and brain metastasis was 4 months, 3 months, 4 months and 3 months, respectively. It is important to evaluate the status of bone and brain metastasis in GC patients with lung or liver metastasis. Knowledge of metastatic patterns is helpful for clinicians to design personalized pretreatment imaging evaluation for GC patients.
登录
查看更多内容
影响因子:
2.6
作者:
Guadagni, S;Catarci, M;Carboni, M
通讯作者:
Carboni, M
影响因子:
6.2
作者:
Jim MA;Pinheiro PS;Carreira H;Espey DK;Wiggins CL;Weir HK
通讯作者:
Weir HK
影响因子:
2.5
作者:
Ahn JB;Ha TK;Kwon SJ
通讯作者:
Kwon SJ
影响因子:
2.5
作者:
KOGA, S;TAKEBAYASHI, M;MAKINO, M
通讯作者:
MAKINO, M
影响因子:
4
作者:
RHOMBERG, W;GRUBER, U
通讯作者:
GRUBER, U